Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Juan Luis Onieva
Observed names:
J. Onieva,
J.L. Onieva,
Juan Luis Onieva Zafra,
Juan-Luis Onieva-Zafra,
Onieva, Juan Luis
Institutions:
Andalusian Centre for Nanomedicine and Biotechnology,
Hospital Clínico Universitario Virgen de la Victoria,
Instituto de Investigación Biomédica de Málaga,
Universidad de Málaga
Observed institutions:
Hospital Regional Universitario de Málaga,
Andalusian Centre for Nanomedicine and Biotechnology,
Hospital Clínico Universitario Virgen de la Victoria,
Instituto de Investigación Biomédica de Málaga,
Universidad de Málaga
ORCID:
0000-0001-8976-8099
Observed ORCID:
0000-0001-8976-8099
OpenAlex ID:
A5063908957
Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study
2022
·
Rodolfo Chicas-Sett
, Juan Zafra
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
50
Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction
2021
·
Javier Oliver
, Marilina Garcia-Aranda
, et al.
·
Seminars in Cancer Biology
·
48
PDF
High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade
2022
·
Juan Luis Onieva
, Qingyang Xiao
, et al.
·
International Journal of Molecular Sciences
·
30
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer
2024
·
Juan Zafra
, Juan Luis Onieva
, et al.
·
International Journal of Molecular Sciences
·
21
PDF
Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma
2022
·
Javier Oliver
, Juan Luis Onieva
, et al.
·
Biomedicines
·
13
Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy
2022
·
Miguel-Angel Berciano-Guerrero
, Rocío Lavado-Valenzuela
, et al.
·
Biomedicines
·
11
Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade
2023
·
Javier Oliver
, Juan Luis Onieva
, et al.
·
Cancers
·
10
PDF
Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC
2026
·
Juan Luis Onieva
, Elisabeth Pérez-Ruiz
, et al.
·
Journal for ImmunoTherapy of Cancer
·
9
PDF
Integrating tumor and immune cell transcriptomics to predict immune checkpoint inhibitor primary resistance in metastatic melanoma
2026
·
Juan Luis Onieva
, Elisabeth Pérez-Ruiz
, et al.
·
OncoImmunology
·
3
PDF
Abstract 1910: flowTOTAL: A comprehensive bioinformatics workflow for flow cytometry automatic analysis
2022
·
Juan Luis Onieva
, Patricia Cháves
, et al.
·
Cancer Research
·
3
Prospective germline exome and machine learning-based risk score identify predictive and prognostic biomarkers of immunotherapy outcomes in advanced non-small cell lung cancer
2026
·
Andrea González-Hernández
, Alberto Ríos
, et al.
·
Journal of Translational Medicine
·
2
Dynamic Exosome Analysis to Predict Response to the Combination of SABR and Immunotherapy in Oligoprogressive Disease
2023
·
J. Zafra Martin
, J.L. Onieva
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
Abstract 3746: Dynamic characterization of small RNAs in non small cell lung cancer exosomes under immune-checkpoint inhibitor treatments
2023
·
Maria Garrido-Barros
, Javier Oliver
, et al.
·
Cancer Research
·
1
1326P Combination of stereotactic ablative radiotherapy with anti-PD-1 in oligoprogressive disease: Final results of a prospective multicenter study
2021
·
J. Zafra
, R. Chicas Sett
, et al.
·
Annals of Oncology
·
1
Abstract 281: Evaluation of circular RNA profiling in metastatic melanoma patients treated with immune checkpoint blockade
2020
·
Juan Luis Onieva
, Javier Oliver
, et al.
·
Cancer Research
·
1
Germline HLA and KIR Variation and Disease Control After Immune Checkpoint Blockade in Non-Small Cell Lung Cancer: Exposure Definition Shapes the Signal
2026
·
Andrea González-Hernández
, Alberto Ríos
, et al.
·
International Journal of Molecular Sciences
Analysis code, audit rules and pre-specification documents for: Germline HLA and KIR Variation and Disease Control after Immune Checkpoint Blockade in Non-Small Cell Lung Cancer: Exposure Definition Shapes the Signal
2026
·
González-Hernández, Andrea
, Ríos, Alberto
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease
2026
·
Juan Zafra-Martin
, Juan Luis Onieva
, et al.
·
OncoImmunology
PDF
Molecular and clinical predictors of NAC response and relapse in HR+/HER2− early breast cancer
2026
·
M. Rosario Chica-Parrado
, Juan Luis Onieva
, et al.
·
Breast Cancer Research
Association between antibiotic use and pathologic response to neoadjuvant chemotherapy in breast cancer: a multicentre retrospective cohort study
2026
·
M. Zalabardo
, I. Fernández
, et al.
·
The Breast
Blood Biomarkers of Survival in Patients Receiving Stereotactic Radiotherapy with or without Immunotherapy for Oligometastatic Disease
2025
·
J. Zafra-Martin
, J.L. Onieva
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Germline NQO1c.559C>T as a biomarker of genetic susceptibility to immune checkpoint blockade resistance.
2024
·
Jose Carlos Benitez
, Javier Oliver
, et al.
·
Journal of Clinical Oncology
PDF
A Cell-Free DNA Methylation Signature to Detect Metastatic Breast Cancer in Blood
2023
·
I. Barragan
, A. Gonzalez
, et al.
·
The Journal of Liquid Biopsy
P1.21-02 Genetic Susceptibility to Immune Checkpoints Blockade Resistance
2023
·
P. Marin
, J.L. Onieva
, et al.
·
Journal of Thoracic Oncology
PDF
Abstract 1044: Cell-free DNA concentration as a prognostic biomarker in patients with non-small cell lung cancer under immunotherapy treatment
2023
·
Isabel Barragan
, Elisabeth Perez-Ruiz
, et al.
·
Cancer Research
Show more works
View as search
Works count:
29
Citation count:
204
H-index:
8
I10-index:
7
Year
Topic
Type